# Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)

> **NCT00635882** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 93 (actual)

## Conditions studied

- Asthma
- Airway Inflammation

## Interventions

- **DRUG:** mometasone furoate/formoterol 100/10 mcg
- **DRUG:** mometasone furoate/formoterol 200/10 mcg
- **DRUG:** mometasone furoate/formoterol 400/10 mcg
- **DRUG:** MF DPI 200 mcg
- **DRUG:** MF MDI 200 mcg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00635882
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00635882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00635882, "Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00635882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*